Mark Hilton "is a great pleasure to work with and provides a first-rate service that combines appropriate staffing and a coordinating role for other jurisdictions in Europe".
Mark is one of the team's pre-eminent litigators, with particular experience advising on complex multi-jurisdictional IP disputes. Mark is a partner in the international intellectual property group. He is based in London. As co-head of the international Life Sciences and Healthcare group, Mark specialises in patent litigation and advice in the area of pharmaceuticals, biosimilars, biotechnology and medical devices. However, his interests and experience also extend to a diverse range of technical fields, in particular the food and beverage and financial services sectors.
In the course of over 20 years of experience of patent litigation, Mark has been involved in devising successful litigation strategies and co-ordinating complex multi-jurisdictional disputes for clients. He is keen to advance the use of technology to improve the delivery of these services to clients and has developed various IT solutions to improve information exchange and make significant improvements to productivity. In particular, Mark has led a project to develop an on-line patent litigation management tool that allows clients immediate access to the status of all of their litigation, efficient communication of instructions and budget control while at the same time reducing the overall cost of the litigation.
Reported UK IP trials in which Mark has been involved include Actavis v Eli Lilly (the landmark case of recent years that introduced, for the first time, a doctrine of equivalents into English law); Smith & Nephew v ConvaTec (successfully defending the validity of a key patent protecting an advanced wound dressing); and Generics (UK) v Yeda (the first case to deal with prior art equivalents following the Actavis v Lilly case and also Arrow declarations in multiple jurisdictions). He also coordinates the trademark enforcement work for one of the major high street banks as well as a motorcycle manufacturing company.
Mark has a BSc in chemistry and a PhD in organic chemistry which he obtained while working in the industry before undertaking training with Bird & Bird. He has written and spoken on a range of IP topics, is an associate of the Chartered Institute of Patent Attorneys (CIPA) and a member of the Law Society of Ireland.